Literature DB >> 10396190

Screening for refractive errors in children: accuracy of the hand held refractor Retinomax to screen for astigmatism.

M Cordonnier1, M Dramaix.   

Abstract

AIMS: To assess the reliability of the hand held automated refractor Retinomax in measuring astigmatism in non-cycloplegic conditions. To assess the accuracy of Retinomax in diagnosing abnormal astigmatism in non-cycloplegic refractive screening of children between 9 and 36 months.
METHODS: Among 1205 children undergoing a non-cycloplegic refractive screening with Retinomax, 299 (25%) had repeated non-cycloplegic measurements, 302 (25%) were refracted under cycloplegia using the same refractor, and 88 (7%) using retinoscopy or an automated on table refractor. The reproducibility of non-cycloplegic cylinder measurement was assessed by comparing the cylindrical power and axis values in the 299 repeated measurements without cycloplegia. The influence of the quick mode on cylinder measurement was analysed by comparing the cylinder and axis value in 93 repeated measurements without cycloplegia where normal mode was used in one measurement and quick mode in the other. Predictive values of the refractive screening were calculated for three different thresholds of manifest astigmatism (> or = 1.5, > or = 1.75, and > or = 2 D) considering as a true positive case an astigmatism > or = 2 D under cycloplegic condition (measured by retinoscopy, on table, or hand held refractor).
RESULTS: The 95% limits of agreement between two repeated manifest cylinder measurements with Retinomax attained levels slightly less than plus or minus 1 D. The 95% limits of agreement for the axis were plus or minus 46 degrees. The comparison of non-cycloplegic measurements in the quick and normal mode showed no significant difference and 95% limits of agreement plus or minus 0.75 D. The mean difference between non-cycloplegic and cycloplegic cylinder values measured by Retinomax reached 0.17 D and was statistically significant. Manifest thresholds of > or = 1.5 D, > or = 1.75 D, > or = 2 D cylinder value diagnosed 2 D of astigmatism under cyclplegia respectively with 71-84%, 59-80%, 51-54% of sensitivity (right eye-left eye) and 90-92%, 95%, 98% of specificity.
CONCLUSION: Without cycloplegia, Retinomax is able to measure cylinder power with the same reproducibility as cycloplegic retinoscopy. No significant difference was found in the cylinder values obtained with the quick and the normal modes. Therefore, the quick mode of measurement is recommended as it is more feasible in children. No difference, which is significant from a screening point of view, exists between the non-cycloplegic and the cycloplegic cylinder value (< 0.25 D). Retinomax diagnoses abnormal astigmatism (> or = 2 D) in a non-cycloplegic refractive screening at preschool ages with 51-84% sensitivity rates and 98-90% specificity rates, depending on the chosen threshold of manifest astigmatism. If 2 D of manifest astigmatism is chosen as a positive test, the positive predictive value of the screening reaches 81-84% and the negative predictive value 91-90% (right eye-left eye).

Entities:  

Mesh:

Year:  1999        PMID: 10396190      PMCID: PMC1722933          DOI: 10.1136/bjo.83.2.157

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  How accurate is the hand-held refractor Retinomax(R) in measuring cycloplegic refraction: a further evaluation.

Authors: 
Journal:  Strabismus       Date:  1998-09

2.  Two infant vision screening programmes: prediction and prevention of strabismus and amblyopia from photo- and videorefractive screening.

Authors:  J Atkinson; O Braddick; B Robier; S Anker; D Ehrlich; J King; P Watson; A Moore
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Baltimore Vision Screening Project.

Authors:  M W Preslan; A Novak
Journal:  Ophthalmology       Date:  1996-01       Impact factor: 12.079

5.  [Early correction of hyperopia and astigmatism in children leads to better development of visual acuity].

Authors:  D Friedburg; K P Klöppel
Journal:  Klin Monbl Augenheilkd       Date:  1996-07       Impact factor: 0.700

6.  Refractive variation during autorefraction: multivariate distribution of refractive status.

Authors:  A Rubin; W F Harris
Journal:  Optom Vis Sci       Date:  1995-06       Impact factor: 1.973

7.  [Refraction in childhood as a risk factor for the development of amblyopia and/or strabismus. Recording a round table discussion at the 89th Congress of the German Society of Ophthalmology 25 September 1991 in Leipzig].

Authors:  W Haase
Journal:  Klin Monbl Augenheilkd       Date:  1994-01       Impact factor: 0.700

8.  Clinical evaluation of the Canon Autoref R-1.

Authors:  N A McBrien; M Millodot
Journal:  Am J Optom Physiol Opt       Date:  1985-11

9.  Infant refraction and accommodation.

Authors:  M S Banks
Journal:  Int Ophthalmol Clin       Date:  1980

10.  Prediction of amblyopia and squint by means of refraction at age 1 year.

Authors:  R M Ingram; C Walker; J M Wilson; P E Arnold; S Dally
Journal:  Br J Ophthalmol       Date:  1986-01       Impact factor: 4.638

View more
  13 in total

1.  Change of refractive state and eye size in children of birth weight less than 1701 g.

Authors:  A R O'Connor; T J Stephenson; A Johnson; M J Tobin; S Ratib; A R Fielder
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

2.  Accuracy of noncycloplegic retinoscopy, retinomax autorefractor, and SureSight vision screener for detecting significant refractive errors.

Authors:  Marjean Taylor Kulp; Gui-Shuang Ying; Jiayan Huang; Maureen Maguire; Graham Quinn; Elise B Ciner; Lynn A Cyert; Deborah A Orel-Bixler; Bruce D Moore
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-06       Impact factor: 4.799

3.  The usefulness of the Retinomax autorefractor for childhood screening validated against a Danish preterm cohort examined at the age of 4 years.

Authors:  H C Fledelius; R Bangsgaard; C Slidsborg; M laCour
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

4.  Global motion perception in 2-year-old children: a method for psychophysical assessment and relationships with clinical measures of visual function.

Authors:  Tzu-Ying Yu; Robert J Jacobs; Nicola S Anstice; Nabin Paudel; Jane E Harding; Benjamin Thompson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-30       Impact factor: 4.799

5.  Accuracy of the Welch Allyn SureSight for measurement of magnitude of astigmatism in 3- to 7-year-old children.

Authors:  Erin M Harvey; Velma Dobson; Joseph M Miller; Candice E Clifford-Donaldson; Tina K Green; Dawn H Messer; Katherine A Garvey
Journal:  J AAPOS       Date:  2009-10       Impact factor: 1.220

6.  Anisometropia in children from infancy to 15 years.

Authors:  Li Deng; Jane E Gwiazda
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-20       Impact factor: 4.799

7.  Intertester agreement in refractive error measurements.

Authors:  Jiayan Huang; Maureen G Maguire; Elise Ciner; Marjean T Kulp; Graham E Quinn; Deborah Orel-Bixler; Lynn A Cyert; Bruce Moore; Gui-Shuang Ying
Journal:  Optom Vis Sci       Date:  2013-10       Impact factor: 1.973

8.  Hand-Held Nidek versus Table-Mounted Huvitz Autorefractors and Their Agreement with Subjective Refraction in Adults.

Authors:  Khulood Muhammad Sayed; Alahmady Hammad Alsmman; Engy Mohammed Mostafa
Journal:  Clin Ophthalmol       Date:  2021-04-01

9.  Performance of the Plusoptix A09 photoscreener in detecting amblyopia risk factors in Chinese children attending an eye clinic.

Authors:  Xiao-Ran Yan; Wan-Zhen Jiao; Zhi-Wei Li; Wen-Wen Xu; Feng-Jiao Li; Li-Hua Wang
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

10.  Accuracy of PlusOptix A09 distance refraction in pediatric myopia and hyperopia.

Authors:  Arnaud Payerols; Claudie Eliaou; Véronique Trezeguet; Max Villain; Vincent Daien
Journal:  BMC Ophthalmol       Date:  2016-06-01       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.